Eden Empire Inc
Eden Empire Inc. invests in and operates in the cannabis sector. It engages in the retail sale of cannabis in Canada and the United States. Eden Empire Inc. is based in Vancouver, Canada.
Eden Empire Inc (EDNEF) - Net Assets
Latest net assets as of April 2022: $-993.26K USD
Based on the latest financial reports, Eden Empire Inc (EDNEF) has net assets worth $-993.26K USD as of April 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.53 Million) and total liabilities ($5.53 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-993.26K |
| % of Total Assets | -21.91% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Eden Empire Inc - Net Assets Trend (2019–2021)
This chart illustrates how Eden Empire Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Eden Empire Inc (2019–2021)
The table below shows the annual net assets of Eden Empire Inc from 2019 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-07-31 | $310.59K | -88.20% |
| 2020-07-31 | $2.63 Million | +4934.41% |
| 2019-07-31 | $-54.43K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Eden Empire Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 844817500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.00 Million | 7479.17% |
| Other Comprehensive Income | $156.92K | 117.38% |
| Total Equity | $133.69K | 100.00% |
Eden Empire Inc Competitors by Market Cap
The table below lists competitors of Eden Empire Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
JX HOLDINGS
MU:JHJ
|
$68.68K |
|
Genomed S.A.
WAR:GEN
|
$68.75K |
|
POWER ASSETS (HEH.SG)
STU:HEH
|
$68.80K |
|
BELGACOM
MU:BX7
|
$68.91K |
|
PEAB3F
SA:PEAB3F
|
$68.50K |
|
4SC (VSC.SG)
STU:VSC
|
$68.47K |
|
KIKKOMAN CORP - Dusseldorf Stock Exchang
DU:KIK
|
$68.45K |
|
SODITECH
PA:ALSEC
|
$68.45K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eden Empire Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 2,631,225 to 133,690, a change of -2,497,535 (-94.9%).
- Net loss of 3,964,049 reduced equity.
- New share issuances of 870,568 increased equity.
- Other comprehensive income increased equity by 30,140.
- Other factors increased equity by 565,806.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.96 Million | -2965.11% |
| Share Issuances | $870.57K | +651.18% |
| Other Comprehensive Income | $30.14K | +22.54% |
| Other Changes | $565.81K | +423.22% |
| Total Change | $- | -94.92% |
Book Value vs Market Value Analysis
This analysis compares Eden Empire Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.77x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-07-31 | $0.00 | $0.00 | x |
| 2020-07-31 | $0.03 | $0.00 | x |
| 2021-07-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eden Empire Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2965.11%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1818.92%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 33.05x
- Recent ROE (-2965.11%) is below the historical average (-1049.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.57 Million |
| 2020 | -182.24% | 0.00% | 0.00x | 1.81x | $-5.06 Million |
| 2021 | -2965.11% | -1818.92% | 0.05x | 33.05x | $-3.98 Million |
Industry Comparison
This section compares Eden Empire Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eden Empire Inc (EDNEF) | $-993.26K | 0.00% | N/A | $68.59K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |